Ambrosia Treatment Center

Children/adolescents

Acamprosate (Campral®) Disulfiram Buprenorphine sub-dermal implant Buprenorphine with naloxone Buprenorphine without naloxone Buprenorphine (extended-release, injectable) Naltrexone (oral) Naltrexone (extended-release, injectable) Medications for HIV treatment Medications for Hepatitis C treatment Lofexidine Clonidine Medications for pre-exposure to prophylaxis Medication for mental disorders Nicotine replacement Non-nicotine smoking/tobacco cessation

Adolescents Young adults Adult women Pregnant/postpartum women Adult men Seniors or older adults Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ) Veterans Active duty military Members of military families Criminal justice (other than DUI/DWI)/Forensic clients Clients with co-occurring mental and substance use disorders Clients with co-occurring pain and substance use disorders Clients with HIV or AIDS Clients who have experienced sexual abuse Clients who have experienced intimate partner violence, domestic violence Clients who have experienced trauma

Substance use treatment Detoxification Transitional housing, halfway house, or sober home Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Outpatient Residential/24-hour residential Outpatient detoxification Outpatient day treatment or partial hospitalization Intensive outpatient treatment Outpatient methadone/buprenorphine or naltrexone treatment Regular outpatient treatment Residential detoxification Long-term residential Short-term residential

Comprehensive mental health assessment Comprehensive substance use assessment Interim services for clients Outreach to persons in the community Complete medical history/physical exam Screening for tobacco use Screening for substance use Screening for mental disorders Professional interventionist/educational consultant Breathalyzer or blood alcohol testing Drug or alcohol urine screening HIV testing STD testing TB screening Metabolic syndrome monitoring Testing for Hepatitis B (HBV) Testing for Hepatitis C (HCV)

Aftercare/continuing care Discharge Planning Naloxone and overdose education Outcome follow-up after discharge Benzodiazepines Detoxification Cocaine Detoxification Methamphetamines detoxification Opioids detoxification

Buprenorphine detoxification Buprenorphine maintenance Prescribes buprenorphine Prescribes naltrexone Relapse prevention with naltrexone Accepts clients using MAT but prescribed elsewhere Lofexidine or Clonidine detoxification

Anger management Brief intervention Cognitive behavioral therapy Contingency management/motivational incentives Motivational interviewing Matrix Model Relapse prevention Substance use disorder counseling Telemedicine/telehealth therapy Trauma-related counseling 12-step facilitation Maintenance service with medically supervised withdrawal after stabilization

Medication routinely used during detoxification HIV or AIDS education, counseling, or support Hepatitis education, counseling, or support Health education services other than HIV/AIDS or hepatitis Substance use disorder education Smoking/vaping/tobacco cessation counseling Individual counseling Group counseling Family counseling Marital/couples counseling Vocational training or educational support (for example, high school coursework, GED preparation, etc.)

Hepatitis A (HAV) vaccination Hepatitis B (HBV) vaccination

Smoking permitted in designated area Vaping permitted in designated area

Acupuncture Case management service Domestic violence services, including family or partner Early intervention for HIV Mental health services Social skills development Transportation assistance

In-network prescribing entity Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere This facility administers/prescribes medication for alcohol use disorder In-network prescribing entity